The June issue of Current Pharmaceutical Design is devoted to a review of the interaction between cannabis and psychosis.
The June issue of Current Pharmaceutical Design is devoted to a review of the interaction between cannabis and psychosis.
***
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.